Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study suggests SARS-CoV-2 Omicron is as deadly as past variants

Study suggests SARS-CoV-2 Omicron is as deadly as past variants

SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

Proximity labeling to identify high-confidence SARS-CoV-2 interactors

Proximity labeling to identify high-confidence SARS-CoV-2 interactors

Pets living in households with COVID-19 are high likely to seroconvert and become ill

Pets living in households with COVID-19 are high likely to seroconvert and become ill

How a COVID support team mitigated SARS-CoV-2 transmission within a university community

How a COVID support team mitigated SARS-CoV-2 transmission within a university community

SARS-CoV-2 inhibition mediated by cellular nucleic acid-binding protein

SARS-CoV-2 inhibition mediated by cellular nucleic acid-binding protein

Study explores SARS-CoV-2 RNA genome's functional interactions with host cell

Study explores SARS-CoV-2 RNA genome's functional interactions with host cell

Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Efficacy of affinity resin containing Galanthus nivalis agglutinin against SARS-CoV-2

Efficacy of affinity resin containing Galanthus nivalis agglutinin against SARS-CoV-2

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

Needle- and adjuvant-free vaccination with non-infectious T4-COVID nanoparticles induces strong immunity in mice

Needle- and adjuvant-free vaccination with non-infectious T4-COVID nanoparticles induces strong immunity in mice

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Infectivity of SARS-CoV-2 Omicron variant in the intestinal tract

Infectivity of SARS-CoV-2 Omicron variant in the intestinal tract

Features of SARS-CoV-2 Omicron BA.2 sublineage spike protein

Features of SARS-CoV-2 Omicron BA.2 sublineage spike protein

Effectiveness of ChAdOx1-S COVID-19 booster vaccine

Effectiveness of ChAdOx1-S COVID-19 booster vaccine

Study suggests aerosol transmission of antibodies may contribute to host protection against SARS-CoV-2

Study suggests aerosol transmission of antibodies may contribute to host protection against SARS-CoV-2

Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia

Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.